@thelancetrheum.bsky.social
The #LancetRheumatology is a clinical #rheumatology journal publishing innovative & practice-changing research & opinion across all #rheumatic & #MSK disorders. 🌐 https://www.thelancet.com/journals/lanrhe/home
NEW RESEARCH—Ixekizumab in children with active psoriatic and enthesitis-related juvenile idiopathic arthritis: a multicentre, open-label, Bayesian trial including a randomised reference group to adalimumab bit.ly/4sDik2E
Plus, linked Comment bit.ly/3P92Y7B
#Medsky #Rheumsky
🍃March issue out now!
New data on cardiac events in #COPD, septic shock, climate change and #TB, and much more
🔗 www.thelancet.com/issue/S2213-...
NEW VIEWPOINT—Paediatric rheumatology care in #Europe: setting children and adolescents into focus bit.ly/4cp7usm #Medsky #Rheumsky
Attending the World Congress on #SystemicSclerosis in Athens next week?
Anna Clark, Editor-in-Chief, invites you to reach out with enquiries.
Explore our scope, reach & impact, commitment to publishing excellence, & more: hubs.li/Q03BLchR0
Attending the #EuropeanLupusMeeting in Lisbon next week?
Aisling O'Brien, Acting Deputy Editor, invites you to reach out with enquiries.
Explore our scope, reach & impact, commitment to publishing excellence, & more: hubs.li/Q03BLchR0
🆕“The identification of distinct and non-guideline-concordant pathways highlights persistent gaps in primary care management of patients with osteoarthritis. These findings underscore the need for targeted primary care interventions to support... care before knee replacement.”
...
Our March 2026 issue is live!
Including research in individuals at risk of developing arthritis, real-world data on anifrolumab in #SLE, #cardiovascular risk in #APS, and childhood-onset Sjögren's disease, plus much more! thelancet.com/journals/lan... #Rheumsky
Cover by @emma-cheng.bsky.social
NEW RESEARCH—Recombinant herpes zoster vaccine in patients with autoimmune rheumatic diseases in Brazil: a double-blind, randomised, placebo-controlled, phase 4, non-inferiority study bit.ly/4bZ4dQe @uspoficial.bsky.social
Plus linked Comment bit.ly/3MzdOD4
#Medsky #Rheumsky
NEWS—Frailty care in England deemed deficient
bit.ly/4qFV16O #Medsky #Rheumsky
NEW podcast episode🎧
Acting Deputy Editor, Aisling O'Brien, talks to Fiona Pearce & Rachel Tattersall about #HLH mortality rates in Europe
Listen now
Apple: bit.ly/3Off8LR
Spotify: bit.ly/3OFqGYM
Full Article: bit.ly/4p5f9hT
#Medsky #Rheumsky
🚀 Just launched – our new #goldopenaccess journal on medical imaging and theranostics!
Learn more about the journal’s mission and explore related content from The Lancet Group today: hubs.li/Q041CgFF0
#medsky
NEW RESEARCH—Patient profiles and early response in patients with systemic #lupus erythematosus initiating #anifrolumab: interim analysis from the ongoing multicentre observational REVEAL study bit.ly/4aj9YWz
Plus, linked Comment bit.ly/3ZliHT6
#Medsky #Rheumsky #SLE
Since their introduction 20 years ago, GLP-1 receptor agonists have revolutionised the treatment of diabetes and obesity. In our Feb editorial we discuss the current data on GLP-1 receptor agonists in rheumatic disease bit.ly/4c4N5Zi
#Medsky #Rheumsky
NEW REVIEW—The path to interception in psoriatic disease: from conceptual clarity to clinical translation
bit.ly/3ZD1NPE #Medsky #Rheumsky
Our Feb 2026 issue is live!
Including total versus partial knee replacement, vagus nerve stimulation in hand #OA, mortality due to #HLH, #pregnancy outcomes in #vasculitis, plus much more! thelancet.com/journals/lan... #Medsky #Rheumsky
Cover art by @emma-cheng.bsky.social
NEW RESEARCH—Long-term outcomes of abatacept in individuals at risk of developing rheumatoid arthritis (ALTO): a randomised, double-blind, placebo-controlled trial bit.ly/4pSERqq
Plus, linked Comment bit.ly/49v27Ga #Medsky #Rheumsky
NEW RESEARCH—Transcutaneous auricular vagus nerve stimulation versus sham stimulation in patients with erosive hand osteoarthritis (ESTIVAL): a randomised, multicentre, double-blind, sham-controlled trial bit.ly/4pKm4xD #Medsky #Rheumsky
NEW podcast episode🎧
Deputy Editor, Sophie Woolven, talks to John Isaacs & Josh Bennett about #sarcopenia and the RAMUS study, which looked at the skeletal muscle effects tofacitinib in #RA
Apple: bit.ly/49fUy6d
Spotify: bit.ly/3YSXxeC
Full Article: bit.ly/45tQXPn
#Medsky #Rheumsky
"the most disastrous year for US public health policy"
The US faces a critical public health crossroads as recent policy shifts threaten decades of progress.
What are the implications for future health security and scientific integrity?
Our Editorial: spkl.io/63326AcVQy
NEW Viewpoint—Oral glucocorticoid pulse therapy: a modest change in clinical practice with major benefits bit.ly/4apjdGd #Medsky #Rheumsky
NEW RESEARCH—Trends in mortality due to haemophagocytic lymphohistiocytosis across 29 European countries from 2011 to 2021: a retrospective, international, population-based study bit.ly/4p5f9hT #HLH @racheltattersall.bsky.social
EBV and #SLE: causal or concurrence?
Read our Jan 2026 editorial bit.ly/49hm6I4
#Medsky #Rheumsky
Our Jan 2026 issue is live!
Including #RheumatoidArthritis, #IgG4-related disease, and #SystemicSclerosis, plus much more! thelancet.com/journals/lan...
#Medsky #Rheumsky
And introducing our cover artist for 2026, Emma Cheng @emma-cheng.bsky.social
NEW REVIEW—Skin cancer in inflammatory arthritis: should we advise screening? bit.ly/3MsvsIc #Medsky #Rheumsky
NEW RESEARCH—Clinical phenotypes, classification, and long-term outcomes of childhood-onset Sjögren's disease into adulthood: a single-centre cohort study
bit.ly/4rCIa77 #Medsky #Rheumsky
NEW RESEARCH—Assessing clinical and cost effectiveness of total versus partial knee replacement (TOPKAT): 10-year follow-up of a multicentre, randomised controlled trial bit.ly/4pAMZMq #Medsky #Rheumsky #Orthosky
Our December issue is live!
Including #ILD in #RA, #Sjögrens disease, and #SystemicSclerosis, plus much more! thelancet.com/journals/lan...
Cover by Sara Gironi Carnevale #Medsky #Rheumsky
NEW—Pan American League of Associations for Rheumatology recommendations for the management of rheumatoid arthritis bit.ly/47WEe8q @panlar.bsky.social @lancetrh-americ.bsky.social
Free to read with registration on lancet.com
NEW COMMENT—Revisiting safety and refining benefit of rituximab–belimumab combination for refractory #SLE bit.ly/4hWxegq #Medsky #Rheumsky
NEW RESEARCH—IgG4-related disease in the Japanese population: a whole-genome sequencing study bit.ly/4oVaGPm
Plus, linked Comment bit.ly/4hOOOmz
#Medsky #Rheumsky